FAScinate Therapeutics, Inc.
https://www.fascinatetherapeutics.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From FAScinate Therapeutics, Inc.
Kainos Progresses Parkinson’s Drug US Trials Amid Deal Prospects
Following ABL Bio’s sizable Parkinson’s disease drug deal with Sanofi early this year, Korean bioventure Kainos Medicine is under the spotlight as its novel PD drug candidate enters Phase II in the US.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice